1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Wintrust Financial reported third-quarter 2025 net income of $216.3 million, or $2.78 per diluted share, up from $170.0 million a year earlier but flat on the per-share measure from the second quarter. Net income for the first nine months rose to $600.8 million, or $8.25 per diluted share, versus $509.7 million, or $7.67, a year earlier. Shareholders should note that third-quarter per-share earnings absorbed one-time preferred stock charges, which the company says excluding would have produced $3.06 per diluted share.
Q3 2025 net income was $216.3 million, up 11% from $195.5 million in Q2 2025 and up 27% from $170.0 million in Q3 2024.
Diluted EPS was $2.78 in both Q3 2025 and Q2 2025, and $2.47 in Q3 2024; non-GAAP EPS excluding one-time preferred stock impacts was $3.06.
Net interest income rose $20.3 million to $567.0 million, while net interest margin fell four basis points to 3.48%.
Net charge-offs increased to $24.6 million from $13.3 million in Q2 2025, while non-performing loans fell to $162.6 million from $188.8 million.
Interparfums reported third-quarter 2025 net sales of $430 million, up 1% from $425 million a year earlier, and nine-month net sales of $1.102 billion, up 1% from $1.091 billion. The release covers sales only and does not include profit or earnings per share; the company will report full third-quarter results on November 5, 2025.
Q3 2025 net sales $430 million vs. $425 million in Q3 2024 (up 1%)
Nine-month 2025 net sales $1.102 billion vs. $1.091 billion (up 1%)
European-based sales rose 5% in Q3 to $295 million; US-based sales fell 6% to $137 million
Full third-quarter results due November 5, 2025; conference call November 6, 2025 at 11:00 am ET
Crown Holdings reported third quarter 2025 results, with net sales of $3,202 million, up from $3,074 million a year earlier, and diluted earnings per share of $1.85 versus a diluted loss of $1.47 in 2024. The company raised its full-year 2025 adjusted diluted EPS guidance to $7.70 to $7.80 and reported it had reached its 2.5x adjusted net leverage target, which matters to shareholders because the company also returned more than $400 million to shareholders in the first nine months through buybacks and dividends.
Q3 adjusted diluted EPS rose 13% to $2.24 from $1.99; income from operations fell to $423 million from $444 million
Full-year 2025 adjusted diluted EPS guidance raised to $7.70 to $7.80; fourth quarter adjusted EPS expected at $1.65 to $1.75
Expected 2025 adjusted free cash flow of approximately $1.0 billion after capital spending of approximately $400 million
Adjusted net leverage ratio reached 2.5x at September 30, 2025, the company's long-term target
W. R. Berkley reported third quarter 2025 net income to common stockholders of $511.0 million, or $1.28 per diluted share, up from $365.6 million, or $0.91, a year earlier. Operating income rose to $440.2 million, and the reported combined ratio was 90.9%, unchanged from the prior-year quarter, so shareholders saw higher profit with steady underwriting results.
Net income $511.0 million ($1.28 per diluted share) vs. $365.6 million ($0.91) in Q3 2024
Operating income $440.2 million ($1.10 per diluted share) vs. $393.0 million ($0.98) in Q3 2024
Reported combined ratio 90.9%, the same as Q3 2024; current accident year catastrophe losses $78.5 million
Record common stockholders' equity of $9.8 billion; book value per share $25.79 at September 30, 2025
RLI Corp. reported third quarter 2025 net earnings of $124.6 million ($1.35 per diluted share), up from $95.0 million ($1.03 per share) a year earlier. Operating earnings rose to $77.0 million ($0.83 per share) from $60.4 million ($0.65), and the combined ratio improved to 85.1 from 89.6, which supports shareholder returns through higher book value per share of $20.41.
Net earnings of $124.6 million ($1.35 per share), up 31.1% from the third quarter of 2024
Operating earnings of $77.0 million ($0.83 per share), up 27.4% from $60.4 million
Underwriting income of $60.5 million on a combined ratio of 85.1, compared with $40.7 million on 89.6 a year earlier
Gross premiums written were flat; net investment income rose 12% to $41.3 million
Zions Bancorporation reported third-quarter 2025 net earnings of $221 million, or $1.48 per diluted share, up from $204 million, or $1.37, a year earlier but down from $243 million, or $1.63, in the second quarter. Results also reflected a $50 million charge-off and a $10 million reserve tied to loans to two related companies where the bank detected apparent irregularities, and the bank has started legal action to recover the amounts owed.
Net interest income rose 8% to $672 million, and net interest margin was 3.28% versus 3.03% a year earlier.
Provision for credit losses was $49 million versus $13 million a year earlier, primarily due to two large related C&I loans.
Estimated CET1 capital ratio was 11.3%, compared with 10.7% a year earlier.
Tangible book value per common share rose 17% to $38.64.
AGNC Investment Corp. reported third-quarter 2025 results, with net income of $806 million, or $0.72 per diluted share, compared with a net loss of $140 million in the prior quarter. Tangible net book value per common share rose 6.0% to $8.28, and the economic return on tangible common equity was 10.6%. Net spread and dollar roll income fell to $0.35 per share from $0.38, and the company raised $345 million of preferred stock and $309 million in net common equity proceeds.
Net income of $806 million, or $0.72 per diluted share, versus a net loss of $140 million, or $(0.17) per share, in Q2 2025
Tangible net book value per common share of $8.28 as of September 30, 2025, up from $7.81 on June 30, 2025
Net spread and dollar roll income of $0.35 per common share, down from $0.38 in the prior quarter; quarterly common dividend declared was $0.36 per share
Issued $345 million of 8.75% Series H preferred stock and 31.0 million common shares through at-the-market offerings for net proceeds of $309 million
ServisFirst Bancshares reported third-quarter 2025 net income of $65.6 million, or $1.20 per diluted share, up from $59.9 million and $1.10 a year earlier. Excluding a $7.8 million loss on securities sales, adjusted diluted EPS was $1.30. Non-performing assets rose to 0.96% of total assets from 0.25% a year earlier, a credit metric shareholders may weigh alongside the earnings gain.
Diluted EPS of $1.20 vs. $1.10 in Q3 2024 (up 9.1%); adjusted diluted EPS of $1.30, up 18.2%
Net income of $65.6 million, up 9.5% from $59.9 million in Q3 2024
Net interest margin of 3.09%, up from 2.84% in Q3 2024; one non-accrual relationship reduced it by about 10 basis points
Non-performing assets were 0.96% of total assets, vs. 0.25% in Q3 2024; a $7.8 million loss was recognized on securities sales
STAAR Surgical released preliminary third-quarter 2025 net sales of $94.7 million, up 6.9% from $88.6 million a year earlier, ahead of its October 23, 2025 stockholder vote on the Alcon merger proposal. The increase relied heavily on a $25.9 million December 2024 China shipment paid in full in the quarter, while distributor orders in China fell and nine-month sales declined year over year. The figures are unaudited and subject to change before the 10-Q is filed.
Q3 2025 preliminary net sales of $94.7 million, up 6.9% from $88.6 million
$25.9 million from the December 2024 China shipment was recognized in Q3 2025 after payment in full
Net sales outside China grew 7.7%, while new orders from China distributors were lower
Nine-month 2025 sales were lower than the prior year, as China distributors reduced inventory by about $80 million to $85 million
Cleveland-Cliffs reported third-quarter 2025 results with revenue of $4.7 billion, down from $4.9 billion in the second quarter. The GAAP net loss narrowed to $234 million from $473 million, and adjusted EBITDA rose to $143 million from $94 million, which shows the steelmaker's losses shrinking even as sales declined. The company also lowered its full-year 2025 capital expenditure and SG&A expectations.
Revenue was $4.7 billion in Q3 2025, compared with $4.9 billion in Q2 2025.
Adjusted net loss was $223 million, or $0.45 per diluted share, versus $250 million, or $0.51 per share, in Q2 2025.
Adjusted EBITDA was $143 million, up from $94 million in Q2 2025.
Full-year 2025 capital expenditure expectation was cut to approximately $525 million from $600 million; SG&A expectation was cut to approximately $550 million from $575 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.